EP3583954A1 — Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds
Assigned to Nsc Pharma & Co KG GmbH · Expires 2019-12-25 · 6y expired
What this patent protects
The present invention relates to a nanodispersion of a birch bark extract characterized in that the nanodispersion is stabilized with at least one phospholipid, whereby such nanodispersion is preferably mixed with a polymer and electrospun to fibers which are useful for treating …
USPTO Abstract
The present invention relates to a nanodispersion of a birch bark extract characterized in that the nanodispersion is stabilized with at least one phospholipid, whereby such nanodispersion is preferably mixed with a polymer and electrospun to fibers which are useful for treating wounds.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.